F-group (family)
7512.1.1.33 Glyco_transf_41
Ligands and drugs
278
Member domains
202
with ligand contacts (≤ 4 Å)
72.7% of members
203
with DrugDomain annotations
73.0% of members
132
with a DrugBank compound
47.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7512.1.1.33 belongs to X-group 7512 UDP-Glycosyltransferase/glycogen phosphorylase, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03435 | UDP | Uridine-5'-Diphosphate | 78 |
| DB03397 | UD1 | Uridine-Diphosphate-N-Acetylglucosamine | 34 |
| DB00141 | NAG | N-Acetylglucosamine | 17 |
| DB18689 | GFB | GDP-L-fucose | 4 |
| DB03309 | NHE | N-cyclohexyltaurine | 3 |
| DB03843 | FOR | Formaldehyde | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UDP | URIDINE-5'-DIPHOSPHATE | 79 |
| 12V | (2S,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-thiopyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 52 |
| UD1 | URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE | 34 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 19 |
| 0YT | 2-acetamido-2-deoxy-5-thio-beta-D-glucopyranose | 4 |
| 44P | 5'-O-[(S)-HYDROXY(PHOSPHONOMETHYL)PHOSPHORYL]URIDINE | 4 |
| 94T | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] propyl hydrogen phosphate | 4 |
| 9C1 | 2-{[(2E)-4-chlorobut-2-enoyl]amino}-2-deoxy-beta-D-glucopyranose | 4 |
| GFB | GUANOSINE-5'-DIPHOSPHATE-BETA-L-FUCOPYRANOSE | 4 |
| UDM | URIDINE-DIPHOSPHATE-METHYLENE-N-ACETYL-GLUCOSAMINE | 4 |
| 9CD | 2-{[(2E)-but-2-enoyl]amino}-2-deoxy-beta-D-glucopyranose | 2 |
| CL | CHLORIDE ION | 2 |
| FOR | FORMYL GROUP | 2 |
| HQV | (2S,3R,4R,5S,6R)-3-[(2E)-but-2-enoylamino]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-thiopyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) | 2 |
| J9S | N-[(2S)-2-(2-methoxyphenyl)-2-{[(2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}acetyl]-N-[(thiophen-2-yl)methyl]glycine | 2 |
| J9V | N-[(2R)-2-(2-methoxyphenyl)-2-{[(2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}acetyl]-N-[(thiophen-2-yl)methyl]glycine | 2 |
| JA4 | N-[(2R)-2-{[(7-chloro-2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}-2-(2-methoxyphenyl)acetyl]-N-[(thiophen-2-yl)methyl]glycine | 2 |
| JA7 | 5-{2-[(1R)-2-{(carboxymethyl)[(thiophen-2-yl)methyl]amino}-2-oxo-1-{[(2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}ethyl]phenoxy}pentanoic acid | 2 |
| JAJ | 4-{2-[(1R)-2-{(carboxymethyl)[(thiophen-2-yl)methyl]amino}-2-oxo-1-{[(2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}ethyl]phenoxy}butanoic acid | 2 |
| LXN | ALLOXAN | 2 |